Literature DB >> 3190657

Chemiluminescence measurements of xanthine oxidase and xanthine dehydrogenase activity in four types of cardiovascular cell.

I A Bailey1, C P Blackwell, B Woodward.   

Abstract

The activity and location of xanthine oxidase (EC.1.2.3.2.) and xanthine dehydrogenase (EC.1.2.1.37) have been measured using luminol-enhanced chemiluminescence in four types of cell from the cardiovascular system (neonatal and adult rat cardiac myocytes, rat aortic vascular smooth muscle cells, rat cardiac fibroblasts and human umbilical vein endothelial cells). The detection system developed was both rapid and reproducible and could be used on sub-milligram quantities of cells. Xanthine oxidase was located primarily in cells derived from the vasculature and especially in endothelial cells, as was xanthine dehydrogenase. Only neonatal myocytes had more dehydrogenase activity than oxidase. The significance of the location and activity of these enzymes is discussed in relation to the pathology of myocardial ischaemia, arrhythmogenesis and microvascular disorders.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190657     DOI: 10.1007/bf02005825

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  38 in total

1.  The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O).

Authors:  W R Waud; K V Rajagopalan
Journal:  Arch Biochem Biophys       Date:  1976-02       Impact factor: 4.013

2.  Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow.

Authors:  R A Kloner; C E Ganote; D A Whalen; R B Jennings
Journal:  Am J Pathol       Date:  1974-03       Impact factor: 4.307

Review 3.  Xanthine oxidase: biochemistry, distribution and physiology.

Authors:  D A Parks; D N Granger
Journal:  Acta Physiol Scand Suppl       Date:  1986

4.  Total ischemia in dog hearts, in vitro. 1. Comparison of high energy phosphate production, utilization, and depletion, and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo.

Authors:  R B Jennings; K A Reimer; M L Hill; S E Mayer
Journal:  Circ Res       Date:  1981-10       Impact factor: 17.367

5.  Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor.

Authors:  G M Rubanyi; P M Vanhoutte
Journal:  Am J Physiol       Date:  1986-05

6.  Free radical mediation of the effects of acidosis on calcium transport by cardiac sarcoplasmic reticulum in whole heart homogenates.

Authors:  M L Hess; E Okabe; P Ash; H A Kontos
Journal:  Cardiovasc Res       Date:  1984-03       Impact factor: 10.787

7.  Electrical properties of individual cells isolated from adult rat ventricular myocardium.

Authors:  T Powell; D A Terrar; V W Twist
Journal:  J Physiol       Date:  1980-05       Impact factor: 5.182

8.  Xanthine oxidase as a source of free radical damage in myocardial ischemia.

Authors:  D E Chambers; D A Parks; G Patterson; R Roy; J M McCord; S Yoshida; L F Parmley; J M Downey
Journal:  J Mol Cell Cardiol       Date:  1985-02       Impact factor: 5.000

9.  Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia.

Authors:  M L Myers; R Bolli; R F Lekich; C J Hartley; R Roberts
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

10.  Human vascular endothelial cells in culture. Growth and DNA synthesis.

Authors:  M A Gimbrone; R S Cotran; J Folkman
Journal:  J Cell Biol       Date:  1974-03       Impact factor: 10.539

View more
  2 in total

1.  Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity.

Authors:  H P Friedl; D J Smith; G O Till; P D Thomson; D S Louis; P A Ward
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

2.  Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients.

Authors:  H P Friedl; G O Till; O Trentz; P A Ward
Journal:  Klin Wochenschr       Date:  1991-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.